Article info

Download PDFPDF

Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab
Free
  1. Correspondence to:
    Antti Kuuliala
    Haartman Institute, Department of Bacteriology and Immunology, PO Box 21 (Haartmaninkatu 3), FIN-00014 Helsingin Yliopisto, Helsinki, Finland; antti.kuuliala{at}helsinki.fi
View Full Text

Citation

Kuuliala A, Nissinen R, Kautiainen H, et al
Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab

Publication history

  • Accepted June 2, 2005
  • First published June 7, 2005.
Online issue publication 
December 12, 2005

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.